Datasets
- 5 results
Search results
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study
Gold, R. (Creator), Radue, E.-W. (Contributor), Giovannoni, G. (Creator), Selmaj, K. (Creator), Havrdova, E. (Creator), Stefoski, D. (Contributor), Sprenger, T. (Creator), Montalban, X. (Creator), Cohan, S. (Creator), Umans, K. (Creator), Greenberg, S. J. (Creator), Ozen, G. (Contributor) & Elkins, J. (Creator), figshare, 26 Jul 2016
DOI: 10.6084/m9.figshare.c.3618185, https://figshare.com/collections/Safety_and_efficacy_of_daclizumab_in_relapsing-remitting_multiple_sclerosis_3-year_results_from_the_SELECTED_open-label_extension_study/3618185
Dataset
-
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis
Meaton, I. (Creator), Altokhis, A. (Creator), Allen, C. M. (Creator), Clarke, M. A. (Creator), Sinnecker, T. (Creator), Meier, D. (Creator), Enzinger, C. (Creator), Calabrese, M. (Creator), De Stefano, N. (Creator), Pitiot, A. (Creator), Giorgio, A. (Creator), Schoonheim, M. M. (Creator), Paul, F. (Creator), Pawlak, M. A. (Creator), Schmidt, R. (Creator), Granziera, C. (Creator), Kappos, L. (Creator), Montalban, X. (Creator), Rovira, À. (Creator), Wuerfel, J. (Creator) & Evangelou, N. (Creator), SAGE Journals, 27 Aug 2022
DOI: 10.25384/sage.c.6169222.v1, https://sage.figshare.com/collections/Paramagnetic_rims_are_a_promising_diagnostic_imaging_biomarker_in_multiple_sclerosis/6169222/1
Dataset
-
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
Gärtner, J. (Creator), Hauser, S. L. (Creator), Bar-Or, A. (Creator), Montalban, X. (Creator), Cohen, J. A. (Creator), Cross, A. H. (Creator), Deiva, K. (Creator), Ganjgahi, H. (Creator), Häring, D. A. (Creator), Li, B. (Creator), Pingili, R. (Creator), Ramanathan, K. (Creator), Su, W. (Creator), Willi, R. (Creator), Kieseier, B. (Creator) & Kappos, L. (Creator), SAGE Journals, 11 Mar 2022
DOI: 10.25384/sage.c.5889512.v1, https://sage.figshare.com/collections/Efficacy_and_safety_of_ofatumumab_in_recently_diagnosed_treatment-naive_patients_with_multiple_sclerosis_Results_from_ASCLEPIOS_I_and_II/5889512/1
Dataset
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study
Gold, R. (Creator), Radue, E.-W. (Contributor), Giovannoni, G. (Creator), Selmaj, K. (Creator), Havrdova, E. (Creator), Stefoski, D. (Contributor), Sprenger, T. (Creator), Montalban, X. (Creator), Cohan, S. (Creator), Umans, K. (Creator), Greenberg, S. J. (Creator), Ozen, G. (Contributor) & Elkins, J. (Creator), figshare, 26 Jul 2016
DOI: 10.6084/m9.figshare.c.3618185.v1, https://figshare.com/collections/Safety_and_efficacy_of_daclizumab_in_relapsing-remitting_multiple_sclerosis_3-year_results_from_the_SELECTED_open-label_extension_study/3618185/1
Dataset
-
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
Cree, B. A. (Creator), Selmaj, K. W. (Creator), Steinman, L. (Creator), Comi, G. (Creator), Bar-Or, A. (Creator), Arnold, D. L. (Creator), Hartung, H.-P. (Creator), Montalbán, X. (Creator), Havrdová, E. K. (Creator), Sheffield, J. K. (Creator), Minton, N. (Creator), Cheng, C.-Y. (Creator), Silva, D. (Creator), Kappos, L. (Creator) & Cohen, J. A. (Creator), SAGE Journals, 1 Jul 2022
DOI: 10.25384/sage.c.6074109.v1, https://sage.figshare.com/collections/Long-term_safety_and_efficacy_of_ozanimod_in_relapsing_multiple_sclerosis_Up_to_5_years_of_follow-up_in_the_DAYBREAK_open-label_extension_trial/6074109/1
Dataset